MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2019 International Congress

    Post-pump chorea and progressive supranuclear palsy like syndrome following major cardiac surgery: A case series

    GW. Kim, KW. Park, NR. Choi, HS. Ryu, HJ. Kim, CS. Lee, SJ. Chung (Daegu, Republic of Korea)

    Objective: We report three patients who developed movement disorders after major cardiac surgery and suggest a common underlying mechanism. Background: Choreiform movement disorder occurs in…
  • 2019 International Congress

    Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

    G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

    Objective: To evaluate the frequency of prescription medications commonly associated with the management of PSP in the community. Background: Progressive Supranuclear Palsy (PSP) is a…
  • 2019 International Congress

    Cerebellar rTMS theta burst for postural instability in progressive supranuclear palsy: a double blind cross-over sham controlled study using wearing sensors technology

    A. Pilotto, MC. Rizzetti, A. Lombardi, M. Biggi, G. Verzeroli, W. Maetzler, C. Hansen, B. Borroni, A. Padovani (Brescia, Italy)

    Objective: To test the efficacy of a single theta burst cerebellar stimulation on postural instability in progressive supranuclear palsy using a cross-over design and wearing…
  • 2019 International Congress

    Neuroart: A Hummingbird in the Cage of the Brain

    A. Kleinert (Tuxtla Gutierrez, Mexico)

    Objective: The main objective of this work is to expose th paintings of an artist with myelomeningocele and her fascination with hummingbirds in patients with…
  • 2019 International Congress

    Relationship between Progressive Supranuclear Palsy and Caregiver Burden

    Y. Inuzuka, J. de Courcy, J. Pike, J. Mellor, E. Viscidi, A. Paradis, A. Harrington, Y. Zabar (Zug, Switzerland)

    Objective: To understand the relationship between progressive supranuclear palsy (PSP) disease progression and caregiver requirement and burden. Background: PSP is a rare neurodegenerative disease, and…
  • 2019 International Congress

    NEUROPSYCHIATRIC SYMPTOMS IN EARLY TO ADVANCED PATIENTS WITH THE RICHARDSON’S SYNDROME VARIANT OF PROGRESIVE SUPRANUCLEAR PALSY

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Marin-Lahoz, J. Perez-Perez, I. Aracil-Bolanos, H. Bejr-Kasem, A. Campolongo, C. Izquierdo, F. Sampedro, J. Kulisevsky (Barcelona, Spain)

    Objective: To know prevalence of neuropsychiatric symptoms in Progressive Supranuclear Palsy along disease stages. Background: Neuropsychiatric symptoms are common features in patients with Progressive Supranuclear Palsy…
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Heavy metals implicated in a geographical cluster of progressive supranuclear palsy induce tau accumulation and apoptotic cell death in cultured neurons

    C. Alquezar, J. Felix, E. Mccandlish, B. Buckley, D. Caparros-Lefebvre, C. Karch, L. Golbe, A. Kao (San Francisco, CA, USA)

    Objective: To test the hypothesis that certain metals may cause cellular damage suggesting tauopathy. This is an early step in testing the hypothesis that environmental…
  • 2019 International Congress

    The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers

    T. Xie, X. Ye, J. de Courcy, K. Golden, Y. Bao, J. Zamudio, L. Chiodo, J. Morgan (Mettawa, IL, USA)

    Objective: To quantify the impact of varying severity levels on caregivers’ burden and health-related quality of life (HRQoL). Background: PSP is a progressive disease. Patients…
  • 2019 International Congress

    Ocular Motor Dysfunction as the Predictable Milestone of Life Prognosis in Progressive Supranuclear Palsy

    T. Ishihara, T. Oeda, S. Tomita, A. Umemura, M. Kohsaka, K. Park, M. Tahara, K. Yamamoto, H. Sawada (Kyoto, Japan)

    Objective: The purpose of this study was to identify which symptoms predict the life prognosis in progressive supranuclear palsy (PSP). Background: Patients with PSP are…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley